Bellerophon Therapeutics
Stock Forecast, Prediction & Price Target
Bellerophon Therapeutics Financial Estimates
Bellerophon Therapeutics Revenue Estimates
Bellerophon Therapeutics EBITDA Estimates
Bellerophon Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $7.62M Low: $7.62M High: $7.62M avg. 0% | |||
Net Income
% change YoY
| $-24.72M N/A | $-17.75M 28.19% | $-19.83M -11.68% | Avg: $-7.44M Low: $-7.44M High: $-7.44M avg. 62.43% | |||
EBITDA
% change YoY
| $-26.70M N/A | $-20.76M 22.26% | $-22.38M -7.82% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$3.17 N/A | -$1.87 41.00% | -$2.08 -11.22% | Avg: -$0.78 Low: -$0.78 High: -$0.78 avg. 62.5% | |||
Operating Expenses
% change YoY
| $26.27M N/A | $20.16M -23.27% | $22.38M 11.02% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Bellerophon Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 62.43% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -7.44M, average is -7.44M and high is -7.44M.
What is Bellerophon Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is $7.62M, average is $7.62M and high is $7.62M.
What is Bellerophon Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 62.5% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.78, average is -$0.78 and high is $-0.78.
What is the best performing analyst?
In the last twelve months analysts have been covering Bellerophon Therapeutics stock. The most successful analyst is Kemp Dolliver.